Pauline M. Camacho MD, FACE

Associate Professor of Medicine and Director of the Loyola University Osteoporosis Metabolic Bone Disease Center

Loyola University Medical Center

Maywood, IL

Pauline M. Camacho MD, FACE is a member of the EndocrineWeb Editorial Board.
She is a Senior Editor and oversees the osteoporosis section of EndocrineWeb.

Pauline Camacho MD, FACE is an Associate Professor of Medicine at Loyola University Medical Center and is the Director of the Loyola University Osteoporosis Metabolic Bone Disease Center. She also directs the Endocrinology Fellowship program at Loyola.

She has published two books on endocrinology: Evidence Based Endocrinology and Osteoporosis: A Guide for Clinicians. She has authored numerous publications and presented in national and international meetings. She is a member of the Board of Directors of the American Association of Clinical Endocrinologists and is on the editorial board of Endocrine Practice and Journal of Clinical Densitometry.

Dr. Camacho completed medical school at the University of the Philippines and her residency at Rush-Presbyterian-St. Luke's Medical Center in Chicago. She maintains an active endocrinology practice.

Disclosures:

Grants/Research Support

Eli-Lilly
Novartis
Proctor & Gamble

Publications / Bibliography:

Books
Camacho, P. (Editor). A Color Atlas of Endocrinology and Metabolism. Manson Publishing. In press.

Camacho P, Gharib H, Sizemore G (Editors) Evidence Based Endocrinology 2nd edition, Philadelphia PA: Lippincott, Williams, and Wilkins; Oct 2006.

Camacho P, Miller P. Osteoporosis: A Practical Guide for Clinicians. Philadelphia PA: Lippincott, Williams, and Wilkins; April 2007.

Camacho P, Gharib H, Sizemore G (Editors) Evidence Based Endocrinology 1st edition. Philadelphia PA: Lippincott, Williams, and Wilkins; May 2003.

Book Chapters
Section Author: American College of Endocrinology Self Assessment Program. 2008.

Painter S, Kleerekoper M and Camacho P. Secondary Osteoporosis. AACE—ASAP, for publication.

Camacho P. Pathogenesis. In Osteoporosis: A Guide for Clinicians. Philadelphia PA: Lippincott, Williams, and Wilkins; 2007.

Camacho P. Secondary Causes of Osteoporosis. In Osteoporosis: A Guide for Clinicians. Philadelphia PA: Lippincott, Williams, and Wilkins; 2007.

Camacho P. Biochemical Evaluation. In Osteoporosis: A Guide for Clinicians. Philadelphia PA: Lippincott, Williams, and Wilkins; 2007.

Camacho P. Acquired Vitamin D Deficiency. In Osteoporosis: A Guide for Clinicians. Philadelphia PA: Lippincott, Williams, and Wilkins; 2007.

Camacho P. Treatment Options. In Osteoporosis: A Guide for Clinicians. Philadelphia PA: Lippincott, Williams, and Wilkins; 2007.

Camacho P. Case Studies. In Osteoporosis: A Guide for Clinicians. Philadelphia PA: Lippincott, Williams, and Wilkins; 2007.

Camacho P, Kleerekoper M. Biochemical Markers in ASBMR Primer. ASBMR Copyright. 2006.

Camacho P. Metabolic Bone Diseases in Evidence Based Endocrinology 2nd edition. Philadelphia PA: Lippincott, Williams, and Wilkins; Oct 2006.

Camacho P. Metabolic Bone Diseases in Evidence Based Endocrinology. Philadelphia PA: Lippincott, Williams, and Wilkins; Jan 2003.

Pitale S, Camacho P, Dejong S. Adrenal Disorders in Evidence Based Endocrinology. Philadelphia PA: Lippincott, Williams, and Wilkins; May 2003.

Nabhan F, Camacho P, Hypocalcemia, in Fluid and Electrolyte Management in Pediatrics. In press.

Invited Reviews and Editorials
Camacho P. Advances in the Evaluation and Treatment of Osteoporosis-Is There an Optimal Regimen? Touch Briefings.

Camacho P, Lopez N. Use of Biochemical Markers of Bone Turnover in the Management of Postmenopausal Osteoporosis. Clinical Chem and Lab Med. 2008;46(10):1345-1357.

Camacho P, Armamento-Villareal, Kleerekoper M. Postmenopausal Osteoporosis: Current and Future Therapeutic Options. Expet Rev Endocrinol Metabol. 2007;2:1,79-90.

Camacho P, Kleerekoper M. Monitoring Osteoporosis. Clin Chem. 2005;51(12):2227-8.

Published Articles and Abstracts
Camacho PM, Dayal AS, Diaz JL, Nabhan FA, Agarwal M, Norton JG, Robinson PA, Albain KS. Prevalence of Secondary Causes of Bone Loss Among Breast Cancer Patients with Osteopenia and Osteoporosis. J Clin Oncol. 2008;26(33):5380-5. Epub 2008 Oct 27.

Camacho P, Mazhari A, Sexton B, Sapountzi P, Sinacore J. Vitamin D Deficiency is Associated with Diminished Quality of Life based on Qualeffo-41 Questionnaire Analysis. J Bone Miner Res. 2008;23:S350.

Camacho P, Mazhari A, Kadanoff R. Adult Hypophosphatasia Treatment with Teriparatide. J Bone Miner Res. 2008;23:S222.

Camacho P, Painter S, Kadanoff R. Treatment of Adult Hypophosphatasia with Teriparatide. Endocr Pract. 2008;14:2:204-208.

Camacho PM, Dayal A, Diaz J, Nabhan F, Agarwal M, Norton J, Robinson P, Albain KS. Prevalence of Secondary Causes of Osteoporosis Among Breast Cancer Patients with Osteoporosis and Osteopenia. J Bone Miner Res. 2007;22:1:S190.

Guiahi M, Gabram SG, Albain KS, Camacho P, Krishnamachari B, Rajan P. Clinical Factors to Support Prophylactic Mastectomy in a Male BRCA1 Carrier. Surgery. 2006;139(5):704-6.

Agarwal M, Camacho P. Bone Densitometry: Interpretation and Pitfalls. Postgrad Med. 2006;119(1):17-23.

Diaz J, Agarwal M, Norton J, Camacho P. Predicting Secondary Causes of Osteoporosis Using DXA Z scores. Endocr Prac. 2006;12(Suppl 2):PGS.

Bachrach L, Camacho P. Clinical Experience with Teriparatide. Endocr Prac. 2006;12(Suppl 2):PGS.

Painter S, Kleerekoper M, Camacho P. Secondary Osteoporosis. Endocr Prac. 2006.

Guiahi M, Gabram S, Albain K, Camacho P, Krishnamachari B, Rajan P. Clinical Factors used to support prophylactic mastectomy for a male BRCA2 mutation carrier. Surgery. 2006;139 (5):704-6.

Camacho P, Girgis M., Sapountzi P, Sinacore J. Correlations between Vitamin D, Parathyroid Hormone, Urinary Calcium Excretion, Markers of Bone Turnover and Bone Density of Patients Referred to an Osteoporosis Center. J Bone Miner Res. 2005;20:S1:S389.

Karas T, Leman C, Sinacore J, Camacho P. A Study Comparing Primary Care and Specialty Physicians’ Approach to Diagnosis and Treatment of Osteoporosis. J Bone Miner Res. 2005;20:S1:S402.

Sapountzi P, Loutrianakis E, Emanuele NV, Camacho P. Prolonged QT in a 15-Year-Old Girl. Endocr Prac. Accepted for publication.

Nabhan FA, Sizemore GW, Camacho PM. Milk-Alkali Syndrome From Ingestion of Calcium Carbonate in a Patient with Hypoparathyroidism. Endocr Prac. 2004;10:4:372-375.

Sapountzi P, Sinacore J, Girgis M, Camacho P. Vitamin D Deficiency is Associated with Diminished Quality of Life based on Qualeffo-41 Questionnaire Analysis. J Bone Miner Res. 2004;19:S1:342.

Nabhan F, Sizemore G, Camacho P. Milk-Alkali Syndrome from Ingestion of Calcium Carbonate in a Patient with Hypoparathyroidism. Endocr Prac.

Peralta M, Emanuele N, Gordon D, Spies S, Camacho P. Thymic Hyperplasia Presenting as a False Positive Whole Body I 131 Scan in a patient with Well-Differentiated Thyroid Carcinoma: A Case Report and Review of Literature. Endocrinologist. 2003;13(1):13-16.

Camacho PM, Pisani B, Bhorade S, Creech S, Nabhan F, Sapountzi P, Hou S, Sizemore G, Van Thiel D. Prevalence of Osteoporosis in Patients Undergoing Evaluation for Lung, Liver, and Heart Transplantation. J Bone Miner Res. 2003;18:S2, S292.

Camacho PM, Islam KK, Peralta MI, Creech SD, Bella N, Nabham FA, Sizemore GW, Van Thiel DH. Oral Antiresorptive Therapy Prevents Bone Loss at the Lumbar Spine One Year After Liver Transplantation. Osteo Int. 2002;13:S1,S133-134 and J Bone Miner Res, 2002;17:S1, S387.

Camacho PM, Sapountzi V. Isolated CRH Deficiency: A Case Series. J Investig Med. 2002.

Stanciu I, Camacho P. Visual Vignette: Metastatic pheochromocytoma. Endocr Prac. 2002;8 (2),138.

Camacho P, Gordon D, Chiefari E, DeJong S, Pitale S, Pitale S, Russo D, Filetti S.
A Phe 486 TSH Receptor Mutation in an Autonomously Functioning Follicular CA. Thyroid. 2000;10:1009-1011.

Camacho P, Pitale S, Abraira C. Review Article: Beneficial and Detrimental Effects of Intensive Glycemic Control. Drugs and Aging. 2000;17(6):463-476.

Pitale S, Camacho P, Gordon D. A Case of Neurosarcoidosis Presenting as a Pituitary Mass. Endocr Prac. 2000;10(6):429-431.

Camacho P, Dwarkanathan A. Sick Euthyroid Syndrome: Abnormal Thyroid Function Tests due to Nonthyroidal Illness. Postgrad Med. 1999;11(4): 215-219.

Camacho P, Mazzone T. Thyrotropin-Secreting Pituitary Adenoma Reponsive to Bromocriptine Therapy. Endocr Prac. 1999;5(5):257-260.

Camacho P, Sizemore G. Visual Vignette: Cushing’s Syndrome due to Topical Corticosteroids. Endocr Prac. 1999;5(4):227.

Pitale S, Camacho P, Abraira C . Cardiovascular Morbidity and Mortality: Control of Risk Factors. Biomedicina. 1999;2(4):179-183.

AACE Medical Guidelines for the Management of Diabetes Mellitus: The AACE System of Intensive Diabetes Self-Management-2000. Diabetes Medical Guidelines Task Force. Endocr Prac. 2000;6(1):42-84.

AACE Clinical Practice Guidelines on the Management of Menopause. RH Cobin and AACE Committee Members. 1999;5(6):355-366.

Estrogen Replacement Therapy for Osteoporosis

If you're approaching menopause, your body will likely alert you to the sudden drop in estrogen with physical signs (such as hot flashes) and psychological changes (including mood swings).

Exercise and Osteoporosis

Bones—like muscles—respond to the stresses placed upon them. So as you strengthen your muscles with exercise, you'll strengthen your bones, too.

Osteoporosis Drugs and Medications

Most people with osteoporosis will need some form of prescription medication. If you have an osteoporosis-related fracture, you will need a medication to help your bones recover and to prevent future fractures. If you've learned you have low bone density but don't have a fracture, you may take a medication to help prevent fractures and further bone loss.

Bracing: An Osteoporosis Treatment Option

The Role of Calcium and Vitamin D in Bone Health

You probably already understand that calcium is good for your bones and helps ward off osteoporosis. The nutrient is essentially a building block of bone, and it helps maintain bone strength throughout your lifetime. But calcium can only reach its full bone-building potential if your body has enough vitamin D.

Osteoporosis Symptoms

Osteoporosis isn’t like most diseases. There are usually no tell-tale symptoms that alert you to its presence early on in its progression. Even if your bones are becoming weaker, you likely won’t feel it.

Osteoporosis Causes

Simply put, osteoporosis occurs when your body absorbs more bone than it produces. In other words, your bones lose density, become weak, and are prone to fractures.

Osteoporosis Complications

Fractures are serious osteoporosis complications—especially if you have one at an older age. If you have a fracture when you're older, your body is less able to recover. At any age, fractures can be extremely painful—and the pain may not go away.

Osteoporosis Overview

Osteoporosis means "porous bone," and it's a disorder characterized by "holey" bones. This might be confusing because if you viewed a healthy bone under a microscope, it would have gaps similar to those in a honeycomb. But an osteoporotic bone contains much bigger spaces than healthy bones.

Osteoporosis Prevention

It's never too early to start thinking about what you can do to prevent osteoporosis. From the foods you eat to the amount of regular physical activity you get, the choices you make impact your health—right down to your bones. Below are four areas to focus your efforts in preventing osteoporosis: